Nanotechnology in dentistry: prevention, diagnosis, and therapy by Abou Neel, EA et al.
© 2015 Abou Neel et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0)  
License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further 
permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on 
how to request permission may be found at: http://www.dovepress.com/permissions.php
International Journal of Nanomedicine 2015:10 6371–6394
International Journal of Nanomedicine Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
6371
R e v I e w
open access to scientific and medical research
Open Access Full Text Article
http://dx.doi.org/10.2147/IJN.S86033
Nanotechnology in dentistry: prevention, diagnosis, 
and therapy
ensanya Ali Abou Neel1–3
Laurent Bozec3
Roman A Perez4,5
Hae-won Kim4–6
Jonathan C Knowles3,5
1Division of Biomaterials, Operative 
Dentistry Department, Faculty of 
Dentistry, King Abdulaziz University, 
Jeddah, Saudi Arabia; 2Biomaterials 
Department, Faculty of Dentistry, 
Tanta University, Tanta, egypt; 3UCL 
eastman Dental Institute, Biomaterials 
and Tissue engineering, London, UK; 
4Institute of Tissue Regenerative 
engineering (ITReN), 5Department of 
Nanobiomedical Science and BK21 
Plus NBM Global Research Center for 
Regenerative Medicine, 6Department 
of Biomaterials Science, College 
of Dentistry, Dankook University, 
Cheonan, Republic of Korea
Abstract: Nanotechnology has rapidly expanded into all areas of science; it offers significant 
alternative ways to solve scientific and medical questions and problems. In dentistry, 
nanotechnology has been exploited in the development of restorative materials with some 
significant success. This review discusses nanointerfaces that could compromise the longevity 
of dental restorations, and how nanotechnolgy has been employed to modify them for providing 
long-term successful restorations. It also focuses on some challenging areas in dentistry, eg, 
oral biofilm and cancers, and how nanotechnology overcomes these challenges. The recent 
advances in nanodentistry and innovations in oral health-related diagnostic, preventive, and 
therapeutic methods required to maintain and obtain perfect oral health, have been discussed. 
The recent advances in nanotechnology could hold promise in bringing a paradigm shift in 
dental field. Although there are numerous complex therapies being developed to treat many 
diseases, their clinical use requires careful consideration of the expense of synthesis and 
implementation.
Keywords: nanotechnology, nanointerfaces, biofilm-related oral diseases, tissue engineering, 
drug delivery, toxicity
Introduction
Nanotechnology as a discipline has rapidly expanded into all areas of science as 
it offers significant alternative ways to solve scientific and medical questions and 
problems. Nanotechnology is a branch of technology that works on the dimensions 
of less than 100 nm. It covers objects such as viruses at around 100 nm size, down to 
glucose molecules at around 1 nm. Hence, it is very much concerned with structures 
at the molecular and atomic scale.
Much of the works that have been carried out over the last 20–30 years (when 
we have seen an explosion in interest in nanotechnology), have been concerned with 
nanoparticles, and these exemplify very clearly why there is such an interest in nano-
technology and the properties of the materials at these length scales. For example, one 
can calculate the surface area of 1 g of powder at different spherical particle diameter 
sizes, and plotting these data shows that below ~100 nm, the surface area per gram 
rises exponentially. This leads to a step change in the properties of these materials as 
properties such as surface energy per gram of material will also change hugely. This 
massive increase in surface area can be exploited for a wide range of applications. 
One of the most simplistic exploitations of nanotechnology is in the pharmaceutical 
industry, where many drugs are poorly or sparingly soluble in aqueous media due to 
their hydrophobic nature. Reducing the pharmaceutical down to the nanoparticle size 
range can allow more of the drug to move into solution due to the massive increase 
in surface area.
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One area of nanotechnology that has been extensively 
utilized in dentistry is that of nanoparticles in composites. 
The rationale for utilization of nanoparticles is two-fold: 
1) to improve the esthetics by making the materials more 
translucent and 2) to improve (or at least modify) the wear 
properties. However, exploitation of nanoparticles in a com-
posite (dental composites or composites more generally) does 
not come without its technical challenges. Nanoparticles, as 
already mentioned, can have extremely high surface charge 
per gram of powder, which can lead to severe and almost per-
manent agglomeration and which can give rise to rapid loss 
or non-attainment of expected properties. One good example 
of this is the processing of carbon nanotubes (CNTs) into 
polystyrene or perspex.1 CNT incorporation into these poly-
mers (as opposed to conventional glass or carbon fibers) can 
give much better mechanical properties (or similar properties 
to the conventional glass or carbon fiber composite), with 
little loss of the optical properties of the unfilled polymer, 
and can also impart the additional functionality of improved 
conductivity, which may be useful.1 To achieve similar rein-
forcing effects, only 0.5–1 wt% of CNTs need to be added 
to the polymer to achieve similar mechanical properties to 
a conventional composite containing 20–30 wt% reinforc-
ing fiber. But at these very low additions, dispersion must 
be absolute and complete to achieve the desired properties, 
and this can be extremely difficult and in some cases impos-
sible to achieve in a cost-effective way as the surface energy 
keeps the particles adherent and leads to agglomeration in 
the composite. However, with a careful understanding of the 
physics and chemistry of the particles, optimal processing 
may be achieved and the desired properties attained.
Another area where nanotechnology has been exploited is 
in the use of submicron grain size ceramics for the production 
of all-ceramic restorations. The logic for using nanometer-
sized powders for the production of ceramic monoliths is 
esthetics and wear properties and also for maximizing the 
strength of the ceramic. Processing of technical ceramics with 
such small grain sizes is technically challenging. Again sur-
face energy plays a major role. During the thermal processing 
stage for a ceramic, surface energy drives the solid-state 
sintering process and can lead to sintering occurring easily 
and rapidly. The small grain size (as well as a non-uniform 
grain size distribution) can also lead to uncontrolled grain 
growth and catastrophic loss of mechanical properties. Thus, 
the synthesis and characterization of the starting material is 
paramount to achieving the properties required.
The aim of this review paper is not to cover all areas of 
nanotechnology as this would not be achievable within a 
single review, but to focus on some areas that have technical 
challenges (eg, oral biofilm and cancers), and to highlight 
how these challenges have been overcome. The recent 
advances in oral health-related preventive, diagnostic, and 
therapeutic methods that could hold promise in bringing a 
paradigm shift in dentistry are the main focus of this review. 
The clinical implementation of these advances requires care-
ful consideration of the expense of synthesis and possible 
nanotoxicity. Since nanotoxicity is a general issue, it has been 
extensively reviewed elsewhere in literature.2–4
Bio-nanointerfaces of clinical 
significance
To restore partial (enamel and dentin) or complete tooth 
loss, dental composite or implants are normally used. The 
retention of resin composite or dental implants is obtained 
mainly through micromechanical retention. The interface 
between resin composites and dental tissues or between 
dental implants and bone is therefore important for the suc-
cess of these restorations. Looking at the structure of enamel, 
dentin, and bone, they are composed of organic matrix, 
mainly collagen and noncollagenous proteins and hydroxy-
apatite (HA). The ratio of the organic to mineral phase varies 
according to the tissue. This section reviews the importance 
of resin composite–tooth as well as implant–bone interface 
and how nanotechnology has been employed to modify these 
interfaces to increase the longevity of resin composites and 
dental implants, respectively.
Adhesive resin–dentin interface
Bonding of dental composites to tooth structure is obtained 
through different adhesive resin systems that depend on 
separate or combined use of etchant, primer, and adhesive 
resin.5 The etchant selectively removes the HA crystals, a 
natural shelter around collagen-rich demineralized dentin 
(Figure 1).6,7 The unprotected collagen network is then more 
vulnerable to enzymatic degradation by endogenous matrix 
metalloproteinases (MMPs)8 and cysteine cathepsins9,10 that 
are released from demineralized collagen. The primer helps 
the subsequent penetration of the adhesive resin. After its 
polymerization, the entanglement of the adhesive resin into 
demineralized collagen network creates a transitional zone 
called hybrid layer or inter-diffusion zone of resin-reinforced 
collagen.11 The polymerized adhesive resin helps to protect 
the collagen from enzymatic degradation; and the long-term 
success of resin composites depends on the integrity and 
durability of adhesive resin–dentin interface. The durability 
of resin–dentin interface can be jeopardized by: 1) degra-
dation of collagen matrix; 2) incomplete penetration and 
polymerization of resin monomer; and c) hydrolysis of the 
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resin monomer. Compromised interface integrity leads to 
nanoleakage, which occurs as spotted, reticular type and 
water trees at the hybrid or adhesive layer.12,13 The nanoleakge 
is always associated with pain, sensitivity, recurrent decay, 
and finally failure of restorations. Nanotechnology has been 
adopted to extend the longevity of resin–dentin bond via: 
1) protection of exposed collagen through reinforcement, 
cross-linking, and biomimetic remineralization; 2) inhibiting 
the action of MMPs; and 3) modifying the adhesive resin 
monomer (Figure 2).
Protection of exposed collagen networks by reinforcement 
with nanofillers or nanogels has been attempted. In addition 
to their protective action, these nanofillers or nanogels could 
help in mineral deposition and hence possible interference 
with MMPs.14 Examples include zirconia (20–50 nm),15 HA 
(20–70 nm),16 colloidal silica (5–40 nm) or barium alumi-
nosilicate nanofillers (400 nm),17 reactive nanogels,18 and 
bioactive calcium/sodium phosphosilicate.14 Cross-linking 
could also improve the nanomechanical properties of the 
exposed collagen network19,20 and hence reduce its degrada-
tion by MMPs.20 Examples of cross-linking agents include 
tannic acid,21 combinations of riboflavin and ultraviolet 
radiation,19 riboflavin and/or chitosan,22 glutaraldehyde,20 
grape seed extract,20 and proanthocyanidins.23 Biomimetic 
remineralization is a recent approach to protect resin-free, 
acid-etched dentin. This approach relies on the use of fluidic 
amorphous nanoprecursors (eg, Portland cement/simulated 
body fluid/polyacrylic acid/poly(vinylphosphonic acid). 
These nanoprecursors can be transformed into mesoscopic 
crystalline intermediates that eventually fuse to form single 
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Figure 1 (A) Optical image of a transverse section of a molar displaying an occlusal cavity, (B) reconstructed optical image of the demineralized region of the dentin in 
the cavity, and (C) AFM image (deflection) of a single dentin tubule from the demineralized region. Aligned collagen fibrils can be observed wrapping around the tubule. 
(D) Higher resolution AFM image of the exposed collagen in the vicinity of the dentin tubule; the D-banding periodicity of collage can be clearly resolved as presented in (E).
Abbreviation: AFM, atomic force microscopy.
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Figure 2 AFM image (deflection) of the interface between a dental composite and 
dentin.
Notes: The dental composite appears very homogeneous, whereas the cross-
sectional cut of dentin can be seen throughout the dentin part. The interface shows 
no apparent gaps. Compromised interface integrity, however, leads to nanoleakage 
that is always associated with pain, sensitivity, recurrent decay, and finally, failure 
of restorations.
Abbreviation: AFM, atomic force microscopy.
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microscopic crystals, ie, a bottom-up nanotechnology 
approach. This technique proved to be successful in remin-
eralizing both interfibrillar and intrafibrillar collagen after 
2–4 months and maintaining the nanomechanical properties 
of normal dentin. It could also help in closing the porosity 
of the adhesive layer.24,25
Inhibition of MMPs action and hence collagen degrada-
tion has been also attempted to improve the longevity of the 
resin–dentin interface. The MMP inhibitor has been used 
as a separate dentin preconditioning step or included within 
the resin adhesive monomer. Examples of these inhibi-
tors include benzalkonium chloride,8 galardin,26 BB94 and 
GM6001,27 chlorhexidine digluconate28,29 and ZnO particles,30 
ethylenediaminetetraacetic acid,31 sodium oxalate,32 titanium 
tetrafluoride and caffeic acid phenethyl ether,33 and phos-
phoric acid/sodium hypochlorite (NaOCl) mixture.34
Self-healing adhesives, capable of closing micro- or 
nanocracks before destroying the integrity of resin–dentin 
bonds, have been also introduced.35 They contain healing 
agent-filled nanocapsules; the rupture of the nanocapsules 
and hence the release of their content is usually initiated by 
the presence of a crack in the resin matrix.36 Nanocontrolled 
molecular interaction between the resin monomer and HA 
remaining within the hybrid layer has also been employed for 
improving the longevity of the resin–dentin interface.6
Dental implant–bone interface
The implant–tissue interface is a key for the success of dental 
implants. Peri-implant healing proceeds from recruitment and 
migration of bone cells to the implant surface through the 
action of persistent blood clot, ie, osteoconduction phase to 
de novo bone formation and finally bone remodeling. Both 
osteoconduction and de novo bone formation are essential 
for providing contact osteogenesis.37 An intimate contact of 
the implant at its neck with the surrounding gingival tissue 
is essential for prevention of bacterial invasion and growth. 
Getting a fusion of the implant root with the surrounding bone 
at both structural and functional levels, ie, osseointegration, is 
crucial for the success of dental implant.38 Implant osseointe-
gration is first achieved through primary mechanical and then 
biological anchorage.39 Microscale modification of topography 
and chemistry of the implant surface indirectly affected implant 
osseointegration, and it could inevitably induce changes at the 
nanoscale level.40 Since cells can directly interact with nano-
scale features, nanotechnology has been introduced to mediate 
bone formation and implant osseointegration.41 Nanoscale 
modification of dental implant surfaces may include both 
surface topography as well as chemistry.
Regarding the surface topography of dental implants, 
several methods, eg, lithography, ionic implantation, 
anodization,42 and radio-frequency plasma treatments, have 
been used to induce controlled nanosurface features 
(eg, tubes,43,44 dots,45 and nodules46) on dental implants. 
These features can be arranged in an organized (isotropic) 
or random (anisotropic) manner to induce altered physico-
chemical behavior (eg, bone bonding) or specific biochemical 
events (eg, altered protein adsorption and cell behavior).47 
Controlling the dimension and spaces between the surface 
nanofeatures/patterns changed cell behavior since cells are 
able to sense the surface and adjust their response accord-
ingly. Changing the diameter of nanotubes from 30 nm 
to 70–100 nm caused the transition of cell behavior from 
adhesion to differentiation.43,44 A spacing between the nano-
features of 58 nm promoted the formation of a stable focal 
adhesion and hence persistence of cell spreading, while 
108 nm spacing produced delayed cell spreading.45 Regard-
ing the bone–implant contact, higher density and curvature 
of 60 nm features demonstrated higher bone–implant contact 
than 120 nm features.48
Since dental implants contact both hard and soft tis-
sues, these implants must therefore have optimum surface 
biocompatibility with the host tissue. Accordingly, chang-
ing the surface chemistry could also be another option to 
enhance osteogenesis. Biofunctionalization, ie, immobi-
lization of specific, active biomolecules known for their 
central role in osteogenesis on the surface of implants, 
was found to be highly effective in promoting firm and 
rapid osseointegration.49 Examples of these biomolecules 
include adhesion molecule (RGD)50 peptide, alkaline 
phosphatase,49 extracellular matrix (ECM) proteins,51 and 
calcium phosphate (CaP) coating.52 Bone morphogenetic 
protein (BMP) has been also immobilized on the surface 
of dental implants to enhance bioactivity and hence bone 
formation.53 BMP allows controlled administration and 
avoids overdosing. In this respect, coating the implant sur-
face with nanocrystalline diamonds increased the surface 
area and facilitated immobilization of BMP.54 In such a 
case, the overall texture of the implant can be maintained, 
while the cellular proliferation and differentiation were 
improved.55 Immobilization of therapeutic agents that 
induce osteogenesis, eg, bisphosphonates and simvastatin,56 
or prevent bacterial infection, eg, silver57 and zinc oxide 
nanoparticles,58 into the biofunctionalized implant surface 
has also been attempted.
Accordingly, for successful dental implants, two con-
flicting properties (ie, enhancement of protein adsorption 
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for cell adhesion but at the same time inhibition of bacterial 
colonization and hence biofilm formation) are required.59 To 
develop this intelligent implant, which will interact with the 
continuously changing environment, deliver the appropriate 
molecule or drug or protein when required, and actively direct 
cell behavior, very challenging robust techniques and reliable 
in vivo experiments are required.
Preventive nanodentistry
Modern dentistry’s goal is to prevent rather than treat biofilm-
dependent oral diseases, eg, dental caries and endodontic and 
periodontal diseases. Nanotechnology offers new approaches 
for preventive therapies in oral diseases, particularly dental 
caries and periodontal diseases.
Dental caries
Dental caries is one of the most prevalent destructive diseases 
affecting tooth structures. It is caused by bacteria, eg, Strep-
tococcus mutans, Streptococcus sobrinus, and Lactobacillus 
spp. These bacteria are usually present in aggregates attached 
to each other and to tooth surfaces in the form of oral biofilms 
or dental plaques. They produce acids that cause deminer-
alization of tooth structures, ie, loss of calcium (Ca) and 
phosphate (PO
4
). Controlling dental caries can be therefore 
gained through inhibiting the bacterial action, reversing the 
demineralization process, and promoting remineralization. 
Development of anti-caries vaccines has also been attempted 
in this respect.
Antibacterial nanotherapy
Several nanoparticles (eg, zinc oxide,60,61 silver,62–64 and 
polyethylenimine65) have been incorporated into dental 
composites66 or dental adhesives67 to inhibit the bacterial 
growth through several mechanisms. These mechanisms 
include disruption of the bacterial cell membrane,68 inhibi-
tion of the active transport as well as the metabolism of 
sugars, generation of reactive oxygen species,69 displacement 
of magnesium ions required for the enzymatic activity of 
oral biofilms,70 disturbance of the electron transportation 
across the bacterial membrane,63 and prevention of DNA 
replication.71 These nanoparticles were effective in reducing 
the S. mutans and Lactobacillus acidophilus biofilms in an 
in vitro model.72,73 Coating tooth surfaces with antibacterial 
nanocoating was found to be effective in killing bacteria 
as well as inhibiting bacterial adhesion and maintaining its 
integrity in the presence of biological fluids (saliva).74 The 
antibacterial action of these nanoparticles was shown to be 
size dependent.75
Biomimetic remineralization – reversing an incipient 
caries
Owing to their colloidal particle size and potential for deliv-
ery of calcium ions, calcium carbonate (CC) nanoparticles 
can have good retention on oral surfaces. They act as a 
delivery vehicle for slow continuous release of high con-
centrations of calcium ions into the surrounding oral fluids 
(saliva and dental plaque). CC nanoparticles also have the 
potential to increase the surrounding fluid pH. Accordingly, 
CC nanoparticles were effective in remineralizing incipient 
enamel lesions when incorporated into an experimental tooth 
dentifrice.76 Nanosized calcium fluoride (CaF
2
), as a labile 
reservoir for fluoride (F), has been shown to be highly soluble 
and reactive with dicalcium phosphate dihydrate compared 
to its macro counterpart. Owing to its high solubility, a great 
amount of CaF
2
 could be consumed by its reaction with dical-
cium phosphate dihydrate, and accordingly, a high level of F 
could be incorporated into the stable reaction product (apa-
tite). Accordingly, a mouth rinse containing nanosized CaF
2
 
showed higher F deposition (2.2±0.3 μg/cm2) than the con-
ventional sodium fluoride (NaF) rinse (0.31±0.06 μg/cm2). 
The CaF
2
 rinse could potentially be used as an anticaries 
agent by increasing the F- concentration in oral fluids and 
thus enhancing tooth remineralization.
Biomimetic remineralization – recurrent decay
Since Ca2+ and PO
4
3- are prerequisites for remineralization, 
several Ca2+- and PO
4
3--releasing dental nanocompos-
ites were developed for their remineralizing action; they 
therefore help in preventing recurrent (secondary) decay 
around or under restorations. Different forms of nanocal-
cium phosphates were used as Ca2+- and PO
4
3--releasing 
fillers, eg, dicalcium phosphate anhydrous,77,78 tetracalcium 
phosphate,79 monocalcium phosphate monohydrate,80 and 
carbonate hydroxyapatite.81 The release of Ca and PO
4
 is 
dependent on degradability and volume fraction of CaP 
form.80 Regardless of Ca and PO
4
 release, these nanocom-
posites could be still used for high-stress bearing applica-
tions since these nanoparticles are used in combination with 
other fillers, eg, whiskers fused with nanosized silica. The 
Ca2+ and PO
4
3- can also be released on demand, ie, when the 
pH has been reduced from neutral to cariogenic level, and 
the level of their release increased dramatically with acidic 
pH.79 Thanks to the chemical binding ability of nanocal-
cium phosphate fillers, eg, carbonate hydroxyapatite, these 
nanoparticles bind to eroded enamel and dentin, forming 
a protective coating, and then reverse the action of acid or 
bacterial attack.81
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Caries vaccine
Several attempts are currently underway in developing an 
effective anticaries vaccine as a new strategy of preventing the 
occurrence of dental caries. DNA vaccine was found to be an 
effective, safe, stable, and inexpensive immunogenic strategy 
in inducing both humoral and cellular immune responses.82 
Many candidate anticaries DNA vaccines have been or are 
undergoing usage tests in animals or human beings. Examples 
of these vaccines include pcDNA3-Pac,83 pCIA-P,84 pGJGLU/
VAX,85 and pGLUA-P.86 Most of the anticaries vaccines work 
by preventing bacterial accumulation either by blocking the sur-
face protein antigen PAc or inactivation of glucosyltransferases 
enzyme.87 Both surface protein antigen PAc and glucosyltrans-
ferases are the virulent factors responsible for the adhesion of 
S. mutans to tooth surfaces.88,89 DNA vaccines, however, have 
poor immunogenicity in large animals and human beings. 
Nanotechnology has been employed to tailor delivery vehicles 
(eg, anionic liposomes in chitosan/DNA nanoparticle complex 
was used as a delivery vehicle90) to enhance the immunogenic-
ity of anticaries DNA vaccine. Furthermore, the surface charge 
of the delivery vehicle could be pH dependent to enable the 
release of the vaccine in a pH-dependent manner.90
Despite the advances in nanotechnology, its clinical 
application for caries therapy is not yet feasible. Although, the 
Ca2+- and PO
4
3--releasing nanocomposites have load-bearing 
capability, their mechanical behavior as Ca2+ and PO
4
3- ions 
being released is difficult to estimate and control under iden-
tical clinical situations. The profile of ions released under 
constrained conditions has not been investigated. A balance 
between the ion release and the rate of caries progression, 
which is unpredictable, must exist. The optimum particle 
size of nanofillers required for remineralization, the pattern 
in which the released ions are precipitated, and the orienta-
tion of precipitated nanocrystals in relation to collagen fibrils 
are important factors that require careful consideration in 
designing nanomaterials. Until now, all in vitro investigations 
indicated that nanotechnology could be effective in reversing 
lesion progression in the outer but not in the deeper part of 
early caries lesions.91 Controlling deep and large lesions, how-
ever, requires a thorough understanding of the caries progres-
sion process. Furthermore, incorporation of nanofillers within 
dental composites might be effective in preventing recurrent 
caries around restorations; the effect of these nanofillers, how-
ever, on bacteria left in affected dentin, which are sometimes 
left in deep cavities during conservation of tooth structures, 
has to be studied. Furthermore, regardless of the progress with 
anticaries vaccinations, their use in human beings has not been 
tried yet. Accordingly, there is no vaccine available on the 
market yet. The high diversity of oral flora, high salivary flow, 
difficult antigen delivery, enzymatic degradation of vaccine, 
and poor internalization could be limiting factors.
Periodontal diseases
Nanotechnology has been used to prevent bone loss in an 
experimental periodontal disease model by local application 
of nanostructured doxycycline gel.92 Nanorobots (dentifro-
bots) mouthwash or toothpaste left on the occlusal surfaces 
of teeth with their continuous and fast movement (1–10 μm/ 
second) across the supra and subgingival surfaces continu-
ously removes the organic residues and prevents the calculus 
accumulation. These nanorobots can be safely deactivated 
when they are swallowed.93
Diagnostic nanodentistry
Considering the impact of nanotechnology in the fields of drug 
delivery and diagnostic and novel material design for implantol-
ogy and tissue regeneration, one may expect the same level of 
engagement of this emerging field in dentistry. However to date, 
there have been very few contributions from the scientific and 
clinical communities reporting an impact of nanotechnology 
on the diagnostics of dental conditions. Diagnostics of dental 
conditions is still nowadays routinely undertaken in clinic using 
a set of guidelines drawn by the best practice in the field. Some 
of these guidelines have not changed in decades for certain 
ailments such as caries or tooth crack syndrome for example. 
It has therefore proven difficult to bring innovative approaches 
when establishing a treatment plan for patients while ensuring 
best outcomes. Thus, unlike in medicine, dentistry has not yet 
seen considerable transition from research laboratory practices 
to clinical chairs. Nonetheless, over the past few decades, con-
tributions arising from nanotechnology in dentistry have been 
made mostly in three fields: atomic force microscopy (AFM), 
imaging contrast enhancers, and biochips.
AFM and oral biofilms
Thorough understanding of bacterial adhesion, the main fac-
tor for bacterial colonization and pathogenesis, as well as bac-
terial nanomechanics is essential for prevention or treatment 
of biofilm-dependent oral diseases.67 Bacteria have the ability 
to adhere to others from the same or different species as well 
as to different substrates, eg, teeth and implants.94,95 With 
the recent technologies, AFM, with its capability to directly 
interact with and image live cells without any disruption of 
their morphology and properties,96 offers a breakthrough in 
characterization of bacteria as well as measurement of their 
adhesion to different substrates (Figure 3).97,98
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With nanomechanical biosensors, AFM cantilever, a 
real-time scanning of a live bacterial cell with high sensi-
tivity was made possible.99 Furthermore, information on a 
cell’s elasticity100 and the membrane-molecules’ properties101 
become available. The way by which bacteria adhere to tooth 
surfaces or dental implants has been revealed using AFM. 
This process usually starts with docking stage where nonspe-
cific reversible attachments between bacteria and substrate 
through van der Waals and electrostatic forces exist. When 
the bacteria become close to the substrates, specific ligand–
receptor interactions are formed, which is the locking stage. 
In this stage, molecules on bacterial surfaces and bacterial 
appendages such as fimbriae, pili, and capsules interact irre-
versibly with the substrate.102 This adhesion depends primar-
ily on type and properties of both bacteria and the substrate 
as well as the surrounding environment.103 The formation of 
a biofilm usually starts with adhesion of initial colonizing 
species to the host surface; the coaggregation of late coloniz-
ing species, which change their phenotype and properties to 
adapt to the established biofilm, then follows.104,105 A biofilm 
is therefore a highly organized population of different adher-
ent bacterial species embedded in a matrix of exopolysac-
charides and proteins.106,107 The presence of different bacterial 
species in a biofilm increases its resistance to antibiotic and 
mechanical removal.108,109 Understanding how the bacte-
rial cells adhere to different cell types110 and substrates at 
both nanoscale and picoscale levels,111 however, helps in 
understanding the biophysics of early phase or oral biofilm 
formation and pathogenesis of diseases. The adhesion of 
bacteria to tooth surfaces varies from species to species, eg, 
microbiomes have higher adhesion forces than planktonic 
bacteria. This could indicate the importance of early adhering 
bacteria for biofilm formation.112 AFM also provides precise 
information on biomechanical interactions of antibacterial 
drugs with a bacterial cell,113 for example, vancomycin binds 
to D-Ala–D-Ala terminal of peptidoglycan precursors of 
bacterial cell walls;99 this could help in the development of 
antibacterial therapies against drug-resistant bacteria.
Imaging contrast enhancers and oral 
cancers
One of the most prominent contributions from nanotechnol-
ogy in the field of dentistry relates to the diagnosis of oral 
cancer lesions. The ability to image these lesions plays a 
critical role in overall cancer management and treatment 
plan design. Standard clinical imaging techniques, such as 
computer tomography (CT), molecular resonance imaging, 
and ultrasound, can be categorized as structural imaging 
techniques. As such, they are able to assist with the identifica-
tion of anatomical patterns as well as the provision of basic 
information regarding tumor location, size, and spread based 
on endogenous contrast. However, in the case of tumors and 
metastases smaller than 5 mm, these imaging techniques 
become less reliable to distinguish between benign and 
cancerous tumors.114,115 In 1895, Wilhelm Roentgen dem-
onstrated serendipitously the use of gold as a contrast agent 
for X-ray imaging as he imaged one of his wife’s (Anna 
Berha’s) hands with a gold ring on her finger. Gold as an 
element exhibits a strong absorption of X-ray and can be 
used as a contrast agent in the form of gold nanoparticles 
(GNPs) for example.
GNPs can be synthesized using approaches such as 
the citrate reduction of aqueous HAuCl
4
 by the Turkevich 
method116 and the Brust–Schiffrin two-phase synthesis 
method, which uses NaBH
4
 as a reducing agent and a 
mercapto-containing binding agent.117 The size distribution 
of the GNPs produced by both these approaches can be tuned 
by altering the chemical ratio of gold to reducing substance. 
Figure 3 (A) AFM image (topography) of Bacillus bacterial infection on a gelatine substrate. (B) 3D reconstruction of a single Bacillus bacterium AFM image.
Abbreviation: AFM, atomic force microscopy.
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Recent progress toward nanotechnology-based CT imaging 
has been made by Hainfeld et al118 following the wider acces-
sibility of GNPs. Their original work focused on the use of 
GNPs to induce in vivo vascular contrast enhancement in 
CT imaging. In their preliminary work,119 the gold particles 
were not functionalized and consequently did not bind to 
any specific cell receptors. To increase the effectiveness 
and the specificity of the targeting of GNPs, it is essential to 
functionalize these particles. The functionalization of GNPs 
is usually accomplished either by direct thiol-modification of 
the targeting ligand or through the attachment of a targeting 
ligand to GNPs that have been modified with a coating mate-
rial (eg, polymer, lipid, and DNA). The functionalization of 
GNPs with a ligand such as polyethylene glycol, for example, 
promotes both stability and persistence in circulation, allow-
ing greater accumulation in the tumor tissue. It also provides 
a hydrophobic barrier to reticuloendothelial system phago-
cytosis and uptake.120 It is however still possible to increase 
the specificity of GNPs by functionalizing their surface with 
antibodies to markers overexpressed in tumors, such as EGF, 
HER2, and folate.121–123 In their approach, Marega et al have 
used a plasma-polymerized allylamine coating to enable the 
bioconjugation of tumor-targeting epidermal growth-factor 
receptor monoclonal antibodies to GNPs.121 Hainfeld et al 
produced HER2-targeted GNPs by coating 15 nm GNPs 
with polyethylene glycol and covalently coupling them to 
anti-HER2 antibodies.118 Popovtzer et al presented an in vitro 
proof of principle demonstration for head and neck cancer 
(oral squamous-cell carcinoma [OSCC]),114 showing that 
the attenuation coefficient for the molecularly targeted cells 
is over five times higher than for identical but untargeted 
cells. In their approach, the bioconjugation of the GNPs to 
the UM-A9 antibody was achieved according to the method 
described by Kim et al.124
Another contribution from nanotechnology arises in the 
detection of tumors using near-infrared (NIR) luminescent 
quantum dots (QDs). QDs are nanometer-scale semiconductor 
crystals composed of elements of groups II–VI or III–V and 
act as an inorganic fluorophore when exposed to an excitation 
wavelength. Metal and semiconductor nanoparticles in the 
size range of 2–6 nm are of considerable interest, due to their 
dimensional similarities with biological macromolecules (eg, 
nucleic acids and proteins). Similar to GNPs, QDs can be cou-
pled to biomolecules, such as transferrin,125,126 immunoglobu-
lin G (IgG),125 biotin,127 streptavidin,128,129 avidin,130,131 nucleic 
acids,132–134 peptides,135 serotonin,136 adenine,137 adenine 
monophosphate,137 and wheat germ agglutinin.126,137 These 
functionalized QDs effectively become luminescent probes 
that can bind with specificity and sensitivity to a variety of 
targets (immunoglobulin G, antigens, glycoproteins, nucleic 
acid sequences, and receptors). The luminescence of QDs is 
photostable with narrow, symmetric emission spectra and 
broad continuous excitation, allowing excitation of multiple 
QDs with a single wavelength.125–127,129,130 These properties 
make QDs very effective for labeling biological species 
in vivo. In 1998, Nie’s and Alivisatos’s groups independently 
reported the use of QDs for imaging of cells and tissues, 
and these studies have sparked the research growth of QD 
applications in life science.125,127
Head and neck squamous-cell carcinoma, also known 
as OSCC, is one of the most common types of cancer in 
oral oncology, representing ~6% of all cases and account-
ing for an estimated 650,000 new cancers and ~350,000 
cancer deaths globally per year.138,139 Selectively targeting of 
squamous tumors is a long-standing problem due to the lack 
of specificity of current drugs. In 2011, Yang et al140 success-
fully used cell-penetrating peptides to conjugate NIR QDs 
for cancer diagnostics. In their pioneering approach, they 
managed to label OSCC with QD conjugates by endocyto-
sis for visual in vivo imaging on a mouse model. Working 
also on OSCC, Bhirde et al141 used a combination of QDs 
and CNT-based drug delivery to target and kill HN13 cells. 
Single wall carbon nanotubes (SWNTs) present remarkable 
opportunities to meet future advanced drug delivery system 
challenges. In a similar approach as described before, novel 
strategies are developed to bind biological molecules such as 
proteins and DNA and smaller molecules onto SWNTs.142–145 
Functionalized, solubilized SWNTs can transport peptides, 
proteins, genes, and DNA146,147 across cell membranes with 
little cytotoxicity,148 making them an attractive carrier for 
both treatment and diagnosis strategies.
The use of QDs is not restricted to cancer diagnostics. 
This technology has also been used in the case of more com-
mon ailments such as dental caries and periodontal diseases 
where biofilms and bacterial infections play an important 
role. In 2003, Kloepfer et al were the first to use QDs for 
bacterial labeling.126 Since this pioneering work, the use of 
QDs has been more widespread and is now used for label-
ing, detection, and quantification of Mycobacterium bovis, 
Bacillus Calmette–Guérin,149 Escherichia coli O157:H7,150 
and Salmonella enterica and serovar Typhimurium151 as well 
as for the simultaneous detection of E. coli O157:H7 and 
S. enterica and S. typhimurium.152 In 2007, Chalmers et al153 
used QDs as luminescent probes to achieve single-cell 
resolution of oral bacteria biofilms. Using conjugated poly-
clonal and monoclonal antibodies bound to the QD surface, 
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they were able to label planktonically grown Streptococcus 
gordonii DL1 cells as well as individual species within 
mixed-species community biofilms. Although this pioneering 
work is very promising, there is still a huge amount of work 
to be done to effectively target the correct species of bacteria 
for diagnostics purposes. The development of conjugation 
solution is currently the limiting factor for this approach to 
be more widespread, and current approaches are only limited 
to the laboratory rather than frontline patient diagnostics.
Biochips and salivary biomarkers
Possibly one of the most exciting uses of nanotechnology in 
oral health diagnostics comes from the emergence and devel-
opment of biochips.154 Biochips are very small devices (less 
than a few millimeters) on which a collection of miniaturized 
test sites (microarrays) are arranged. The main advantage 
of the microchips over more traditional approaches is that 
many tests (diagnostics) can be performed simultaneously in 
order to achieve higher throughput and speed. Early work in 
this field related to dental diagnostics started in 2002 as the 
National Institute of Dental and Craniofacial Research in the 
USA initiated a concerted research effort in the area of saliva 
diagnostics. National Institute of Dental and Craniofacial 
Research funded several awards to develop microfluidics 
and microelectromechanical systems (MEMS) for saliva 
diagnostics with the aim to identify technologically viable 
systems and support their advancement toward commercial-
ization. This unique venture focused on the development of 
microfluidic and MEMS technologies for measuring DNA, 
gene transcripts (mRNA), proteins, electrolytes, and small 
molecules in saliva, as well as overall profile correlates of a 
particular disease state, such as cardiovascular disease.155,156 
One particular success came from Segal and Wong157 who 
found out that discriminatory and diagnostic human mRNAs 
are present in saliva of normal and diseased individuals. 
The salivary transcriptome presents an additional research 
and clinical resource, the second saliva-based diagnostic 
alphabet for disease detection. This work led to the devel-
opment of salivary diagnostic technology using MEMS and 
nanoelectromechanical system biosensors. These devices 
exhibit exquisite sensitivity and specificity for analyte detec-
tion, down to single-molecule level.158,159 Subsequently, the 
research consortium led by Wong developed the oral fluid 
nanosensor test.157,160–162 This handheld, automated, easy-
to-use, integrated system enables simultaneous and rapid 
detection of multiple salivary protein and nucleic acid targets. 
In 2007, Gau and Wong suggested that the intended use of 
the oral fluid nanosensor test is for point-of-care multiplex 
detection of salivary biomarkers for oral cancer.160 In their 
work, they demonstrated that the combination of two salivary 
proteomic biomarkers (thioredoxin and interleukin-8 [IL-8]) 
and four salivary mRNA biomarkers (SAT, ODZ, IL-8, and 
interleukin-1 beta [IL-1β]) can detect oral cancer with high 
specificity and sensitivity.
Another important emerging tool in oral health diagnos-
tics involves profiling methods that are available for detecting 
miRNA expression levels and were recently reviewed by 
Yoshizawa and Wong.161 miRNAs are short noncoding RNA 
molecules that play important roles in regulating a variety of 
cellular processes. Dysregulation of miRNAs is known to be 
associated with many diseases, such as OSCC. The presence 
of miRNAs in saliva and their potential as non-invasive bio-
markers in oral cancer detection was shown to be an effective 
marker in the case of OSCC using miR-31over-expression.163 
The profiling methods involve biochemical techniques, such 
as quantitative PCR,164,165 microarray hybridization,166,167 
and next-generation sequencing. The miRNAs present in 
saliva are very low, typically in the nanogram range upon 
extraction. The challenge of these profiling methods is thus 
to be able to quantify very low quantities of the miRNAs 
present in saliva, which is typically in the nanogram range 
upon extraction. An example of such profiling techniques 
is Applied Biosystems Stem-loop RT based TaqMan® 
MicroRNA Assay. This method measures quantitation for 
mature miRNA expression and is believed to be the gold-
standard method with a large dynamic range, high specificity, 
and high sensitivity.164,168,169
Another venture in the field of biochips comes from the 
work initiated by Weigum et al on the development of a 
diagnostic cytology-on-a-chip technique that rapidly detects 
premalignant and malignant cells with high sensitivity and 
specificity.170,171 In their approach, they designed a sensor for 
the diag nostics of OSCC, which integrates multiple labora-
tory processes onto a microfluidic platform in three primary 
steps. First, an oral-cytology suspension is delivered to the 
sensor using pressure-driven flow, where any cells larger 
than the membrane-pore size are retained on the membrane 
surface.170,171 The captured cells are then stained with fluo-
rescent dyes and immunoreagents to distinguish the cyto-
plasm, nucleus, and cancer biomarkers. In their diagnostic 
approach, they selected epidermal growth-factor receptor 
as the targeted biomarker, since it is overexpressed and 
well characterized in OSCC and associated with aggressive 
phenotypes. Finally, the stained cells are subjected to a 3D 
fluorescence-microscopy scan of the membrane surface. This 
is followed by automated image analysis using open-source 
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software. The advantage of this approach is the speed at 
which a diagnosis can be made.
In the field of periodontal diseases,162 Christodoulides et al 
have developed an electronic microchip-assay to detect 
C-reactive protein (CRP), which is a biomarker for inflam-
mation associated with periodontal disease at the picogram 
per milliliter level.172 CRP is known to be a systemic marker 
produced as a response to inflammatory stimuli173 that can 
be used to differentiate in serum, between a healthy state 
and the presence of periodontitis174,175 and saliva.176 It is the 
ability of the biochip to detect very low concentrations of 
CRP present in the saliva compared to serum that has enabled 
the researchers to distinguish between healthy periodontium 
and chronic gingival inflammation based directly on salivary 
CRP levels.177 Moreover, CRP is also classified as a systemic 
marker of inflammation that has been shown to significantly 
increase in other conditions, including myocardial infarction, 
atherosclerosis, and arthritis.178–180 Another device called 
the integrated microfluidic platform for oral diagnostics 
was developed to perform immunological assays in less 
than 10 minutes with low sample volume and concentration 
requirements to test for periodontal disease.181 This device 
is able to detect proteins in the picomolar range for tumor 
necrosis factor-α (TNF-α) and interleukin-6 (IL-6) that have 
been spiked into saliva. IL-6 is released in response to IL-1 
and TNF and has been shown to increase proportionally 
with bone loss in adult chronic periodontitis patients.182 The 
proinflammatory and immune regulatory cytokine, TNF-α, 
has been identified in saliva and is significantly elevated in 
people with periodontitis compared with healthy individu-
als, with increased levels being correlated with increased 
numbers of sites with bleeding upon probing, pocket depth, 
and higher clinical attachment levels.183,184
Toward clinical trials
It is clear that there is an effort by the scientific communi-
ties to develop new tools to diagnose dental ailments more 
locally, more precisely, and with a lesser amount of analytes. 
However, it is also evident that the current level of research 
undertaken has not yet yielded methods or devices that can be 
used in a widespread manner for clinical trials. There is a clear 
lack of clinical trials associated with any nanotechnology-
based diagnostic approaches in the current literature. Most 
of the current nanoscale diagnostic approaches applied to 
dentistry evolve from the vast number of strategies currently 
used in medicine, as was seen for cancer. There are a number 
of isolated clinical cases or reports suggesting that the 
field of dentistry is slowly appreciating the merits of these 
approaches. Dentistry is traditionally a very conservative 
discipline, and this may explain the reason for the current reti-
cence to use these novel approaches. Nanotechnology is yet 
to find a diagnostics solution for common ailments, such as 
dental decay and erosion, and has only started to find a solu-
tion in the field of periodontology. Until nanotechnology can 
bring more advanced methods to diagnose or prognose such 
common conditions, nanotechnology’s impact may be limited 
in terms of a diagnostic tool in the field of dentistry.
Therapeutic nanodentistry
The use of nanotechnology in treating dental diseases has 
found a great interest. Its use has been extended from treat-
ing dentin hypersensitivity, root canal disinfection, and oral 
cancer to the most recent use in tissue engineering and drug 
delivery applications.
Dentin hypersensitivity
Dentin is protected from external stimuli by enamel in the 
crown or by cementum in the root. The removal of this pro-
tective layer exposes the underlying dentinal tubules, chang-
ing the fluid pressure hydrodynamics of the fluid inside the 
dentinal tubules, and is believed to be responsible for dentin 
hypersensitivity. GNPs were found to be easily adsorbed 
on the inner dentinal tubule walls; the application of silver 
staining was then used to help to occlude the open tubules 
and reduce the dentin sensitivity. After brushing the opened 
tubules with highly concentrated GNPs, laser irradiation 
promoted the aggregation of nanoparticles to occlude the 
exposed tubules.185 Furthermore, dental nanorobots offer 
a quick and permanent cure to dentin hypersensitivity by 
selectively and precisely occluding the tubules in minutes 
using biological materials.186
Root canal disinfection
Several nanoparticles, such as zinc oxide and chitosan alone 
or in combination, have been incorporated into root canal 
sealers in an attempt to disinfect root canals. They had no 
effect on the flow characteristic of the sealers, but they 
enhanced the antibacterial action, observed by a significant 
reduction in Enterococcus faecalis adherent to treated 
dentin.187 Prior surface treatment of root canal dentin with 
phosphorylated chitosan was effective in maintaining the 
inhibitory effect of a chitosan-modified root canal sealer 
on biofilm formation at the sealer–dentin interface.75 Metal 
oxides such as magnesium oxide nanoparticles could be used 
as a potential root canal irrigant with promising antibacte-
rial activity in both in vitro and ex vivo studies. Compared 
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to the conventional NaOCl solution (5.25%), magnesium 
oxide nanoparticles (5 mg/L) showed statistically significant 
long-term effect in the elimination of E. faecalis adherent to 
root canal dentin.188
Oral cancers
In cancer radiation therapy, GNPs were conceived as a radio-
sensitizer and they caused cell death after gamma radiation. 
The radiosensitivity of GNPs is dependent on their sizes.189 In 
cancer chemotherapy, nanodelivery vehicles (eg, naringenin-
loaded nanoparticles in 7,12-dimethylbenz(a)anthracene)190 
were used for improving the stability as well as targeted and 
controlled delivery of chemotherapeutic drugs. In photother-
mal therapy, this relies on the use of a plasmonic probe and NIR 
light, recently introduced as a minimally invasive technique 
for the treatment of deep tissue malignancy such as OSCC.91 
In this therapy, GNPs, with their enhanced NIR absorbance 
and ability to convert the absorbed light into heat energy, 
were used as a plasmonic nanoprobe. The nanodimension 
of this probe ensures its easy absorption by the localized 
tissue, reduces its toxicity, and allows its removal from 
the body after the treatment. Further enhancement of their 
biocompatibility, coating the gold nanostructures with 
thermo and pH-responsive polymers, for example poly(N-
isopropylacrylamide-co-acrylic acid), has been attempted. 
RGD (arginine-glycine-aspartate) and NLS (nuclear local-
ization sequence) peptides-conjugated nuclear targeting gold 
nanostructures can be easily captured by cancerous cells 
(eg, OSCC), subsequently disturb their functions (DNA 
damage, induces cytokinesis arrest in cancer cells) inducing 
cell apoptosis and necrosis.191 The composition and shape 
of these nanostructures (eg, nanorods,91 nanospheres, and 
nanocages192) would further enhance their apoptotic activity. 
In addition to disruption of cellular functions, gold nanocages 
produced reactive oxygen species that also kill the cancerous 
cells.191 Selective inhibition of cancer cell growth through 
mitochondria-mediated autophagy has been obtained by 
iron-core–gold shell nanoparticles.193
In addition to treating cancer, nanotechnology has been 
also extended to offer an effective management of the 
breakthrough pain associated with cancer. A nanodelivery 
transbuccal system was developed to rapidly and efficiently 
deliver the opioid analgesia at a consistent and controlled 
diffusion into the target tissue. Accordingly, it minimizes the 
risk of overdosing in patients and also protects the patients 
from needle injection. It also avoids the enzymatic and 
spontaneous degradation of the drug associated with oral 
administration.194
Tissue engineering
Tissue engineering in dentistry, like other medical areas, has 
been approached to combine the technologies of scaffold 
matrices with the regenerative power of stem cells, which can 
be sourced mainly from dental tissues such as dental pulp, 
periodontal ligament (PDL), and alveolar bone.195 The scaf-
folding matrices need to have specific functionality, such as 
to provide surfaces that allow cell attachment, proliferation, 
and differentiation as well as to present porous networks that 
enable the penetration of cells and nutrients.196 Furthermore, 
the matrices need to degrade at an appropriate rate to meet 
the regeneration speed of tissues while preserving a certain 
level of mechanical integrity.196
Nanotechnology in tissue engineering has allowed sig-
nificant improvement of these scaffolding materials to pres-
ent unique 3D matrix conditions for cells and tissues.197,198 
Nanoengineered scaffolds possess intrinsic mechanical 
properties of materials that cannot be readily achieved by 
conventional technologies. The nanotopological surfaces 
provide more definitive physicochemical cues to cells that 
can recognize the nanoscale structures in their adhesion 
and differentiation. Furthermore, many biological proteins 
and active molecules can be integrated with the scaffolding 
materials at the nanoscale level to exert therapeutic efficacy 
and to spatially control the cellular behavior. Therefore, the 
nanotechnology-driven tissue engineering can achieve native 
tissue mimicking architectures and/or evoke the phenomena 
that occur in nature, ultimately to create constructs that are 
equivalent to tissues in dentistry, including dentin, pulp, PDL, 
cementum, and alveolar bone.
Some examples in biology highlight the hierarchical 
organization of tissues at the nanoscale, which ultimately 
informs insights into the design rationale for scaffolding 
matrices by nanotechnology. For instance, the ECM of many 
connective tissues is composed of collagen fibers that are 
formed through self-assembling of smaller subunits. The 
collagen molecules with a triple helical structure assemble 
once they are secreted into the extracellular space, forming 
collagen fibrils, which in turn form collagen fibers that range 
in sizes between 50 nm and 500 nm. In bone, the collagen 
self-assembled fibrils/fibers can template the mineralization 
of HA nanocrystals in a highly ordered manner. To engineer 
this hierarchical nanocomposite bone structure, a lot of effort 
has been exerted. The self-assembling peptides could be 
designed to mimic this, through modifying the amino acid 
sequences that could act as nucleating sites of the mineral 
phase.199,200 The process can also control the crystallographic 
orientation of the HA, which aligns along the c-axes with 
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the long axes of the organic fibers, similar to that found in 
bone.199
Such a bottom-up approach to create native tissue archi-
tecture can provide an engineered construct with unique 
mechanical properties. In fact, enamel in the teeth is believed 
to form through the mineralization of an amelogenin-based 
matrix protein, allowing the precipitation of nanometric 
crystals with perfect organization that ultimately confers hard 
and strong mechanical functions placed in tooth surface.201 
Furthermore, the unique mechanical properties of dentin can 
also be created by the HA mineralization in the dentin matrix 
proteins, which feature the assembly of acidic clusters into 
beta-sheet for hierarchically oriented mineral formation.202 
Therefore, exploiting the nanoarchitecture of the native den-
tal tissues has often been a topic of research in dental tissue 
engineering scaffolds. The electrospun nanofibers,203–205 self-
assembling peptides,206,207 and phase-separation matrices208,209 
are the representative cases.
The nanofibrous scaffolds have been widely developed 
as the matrices for regeneration of dental tissues, including 
dentin–pulp complex, enamel, PDL, cementum, alveolar 
bone, and temporomandibular joint. A key aspect of the 
nanofibrous structures is their morphological trait largely 
mimicking the native tissue architecture because most of 
tissue proteins such as collagen and elastin are nanofibrous. 
Owing to their large surface area relative to volume, the 
surface-related properties are dominant, and these include 
surface reactivity, protein adsorption, and surface degrada-
tion, which ultimately control the cellular behaviors.210,211
Dentin and pulp are one of the most widely explored 
dental tissues utilizing the nanofibrous scaffolds. Nanofi-
brous scaffolds can be produced either by phase-separation, 
electrospinning, or peptide synthesis approach. For example, 
nanofibrous scaffolds made of poly-l-lactide acid (PLLA) 
could be synthesized through phase-separation and porogen 
leaching methods. The scaffolds exhibited the stimulation 
of odontogenic differentiation in human dental pulp stem 
cells when compared to solid-walled PLLA scaffolds.208,209 
Furthermore, when ectopically implanted for 8 weeks in 
nude mice, the nanofibrous matrix provided excellent 3D 
environments for dental pulp stem cells to regenerate dental 
pulp as well as dentin.208
Electrospinning is a more common method to generate 
nanofibers. Some recent studies have developed nanocom-
posite nanofibrous scaffolds made of biopolymers with 
bioactive glass, where the bioactive glass role was to provide 
high bioactivity.204,212 The dental pulp stem cells showed 
improved proliferation, differentiation, and mineralization 
on the nanofibers containing bioactive glass when compared 
to the pure polymer nanofibers.204,212 When combined with 
nanohydroxyapatite, the electrospun biopolymer nanofibers 
were also demonstrated to have improved proliferation and 
odontogenic differentiation of dental pulp stem cells.205,213,214 
These studies implicated the importance of bioactive inor-
ganic nanoparticles that possibly play significant roles in 
improving mineralization and remineralization of dentin 
matrices that are damaged and diseased.215 An interesting 
study reported nanofibrous scaffolds that incorporate mag-
nesium phosphate, where the magnesium ions were shown 
to be sustainably released and to play a role in enhancing the 
differentiation of dental pulp stem cells.216 Furthermore, when 
these stem cell-cultured scaffolds were ectopically implanted 
in nude mice, a greater level of ECM deposition, hard tis-
sue formation, and expression of marker proteins could be 
achieved when compared to the Mg-free scaffolds, showing 
the importance of ions in odontogenesis.216
Peptide self-assembly is an intriguing method that enables 
a bottom-up approach to generate nanofibers. As a repre-
sentative example for dentin–pulp regeneration, the RGD 
sequence was designed in the peptide nanofiber scaffolds to 
control dental pulp cellular behaviors. The dental pulp stem 
cells were shown to express odontoblast-like phenotypes, and 
the deposition of mineral was possible.217 Another study to 
mimic the native dentin structure used a methacrylate-based 
matrix with interpenetrated silica nanophase, which enabled 
aligned pores in the micrometer range. The matrices were 
shown to form a neodentinal cellular pattern distribution once 
implanted subcutaneously in mice.218 These matrices with 
nanofibrous structures can be potential scaffolding platforms 
in the stimulation of dental pulp stem cells and ultimately in 
the engineering of dentin–pulp complex tissues.
The nanofibrous matrix has also been developed to mimic 
the enamel. Enamel consists mainly of crystalline HA and is 
the external layer of tooth; therefore, its erosion or a caries 
attack may affect the dentin hypersensitivity. A couple of 
approaches have been proposed using nanomaterials to regen-
erate enamel. One exemplar study used electrospun polymer 
nanofibers containing amorphous CaP. In the presence of F 
ions, the amorphous CaP was able to transform into a con-
tiguous overlayer of crystalline fluoridated apatite of 500 nm 
in thickness (Figure 4A–C).219 Another interesting approach 
was based on self-assembling peptides, which contain high 
amounts of Arg-Gly-Asp (RGD) sequences. The unique 
structure allowed the ability to induce proliferation and differ-
entiation of ameloblasts, which were able to synthesize, orga-
nize, and biomineralize enamel nodules (Figure 4D and E). 
However, compared to other tissues like dentin, the regen-
eration of enamel structures remains a significant challenge 
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Figure 4 Ability of electrospun nanofibers containing ACP to regenerate dentin structure, as revealed by TEM image (A). Dentin cross-section imaged after etching (B) and 
after treatment with hydrated ACP/PvP (C), showing occlusion of tubules (green arrows). Regeneration of enamel by self-assembling peptides, showing aligned HA crystals 
sectioned longitudinally (arrows) and in cross-section (arrowheads) (D), representing considerable resemblance to that of authentic enamel (E). Molecular models of designed 
peptides RADA16 and PRG (F) and the formation of the self-assembled nanofiber present a beta-sheet structure (G). Periodontal ligament fibroblasts cultured in collagen gel 
in the presence or absence of the functional peptide, showing the ability of cells to penetrate into the gel when the PRG sequences were present in the gel (H). (A–C) Adapted 
from Fletcher J, Dominic W, Emma Fowler C, Mann S. Electrospun mats of PVP/ACP nanofibres for remineralization of enamel tooth surfaces. Cryst Eng Comm. 2011;13:3692 
with permission of The Royal Society of Chemistry.219 (D and E) Adapted from Biomaterials, 31, Huang Z, Newcomb CJ, Bringas P Jr, Stupp SI, Snead ML, Biological synthesis 
of tooth enamel instructed by an artificial matrix, 9202–9211, Copyright © 2010, with permission from Elsevier.206 (F–H) Adapted from Kumada Y, Zhang S. Significant type I 
and type III collagen production from human periodontal ligament fibroblasts in 3D peptide scaffolds without extra growth factors. PLoS One. 2010;5:e10305.207
Abbreviations: ACP, amorphous calcium phosphate; TeM, transmission electron microscopy; PvP, poly(vinylpyrrolidone); HA, hydroxyapatite.
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as the erupted enamel is principally acellular, and thus, the 
involvement of progenitor/stem cells can be considered mainly 
at the early stage of tooth development.206
The periodontal pockets, including PDL, cementum, and 
alveolar bone, have also been in great need of nanostructured 
scaffolds for engineering. The electrospun nanofibers of 
poly(lactic-co-glycolic acid) (PLGA) or gelatin were used 
to culture human PDL cells, showing the ability to adhere, 
proliferate, and osteogenically differentiate.203,220 The incor-
poration of silica or HA nanoparticles on the surface of these 
nanofibers has been shown to enhance protein adsorption, 
which resulted in improved adhesion of PDL fibroblast 
cells.221 When the scaffolds contained nanosized HA, protein 
adsorption, cell adhesion, and in vivo bone formation were 
significantly higher than scaffolds containing conventional 
HA.222 When PDL stem cells were seeded on the engineered 
nanosurface, cell viability and differentiation were enhanced 
compared to the absence of the nanosized HAs. The silk scaf-
folds were also tailored with nanohydroxyapatite to have min-
eralized surface.223 The scaffolds constructed with PDL stem 
cells demonstrated substantial level of periodontal regenera-
tion in an in vivo implantation in dogs, suggesting a potential 
scaffolding matrix for periodontal tissue engineering.223 In 
a similar way, the nanosized bioactive glass particles were 
incorporated into alginate scaffolds, which showed enhanced 
proliferation and differentiation of human PDL fibroblasts 
when compared to the alginate-only scaffolds.224 Other than 
the electrospun nanofibers, the self-assembling peptides con-
taining the RGD-binding sequences (PRG) and laminin cell 
adhesion motif (PDS) were designed, which demonstrated 
significant promotion of PDL fibroblast adhesion, prolifera-
tion, and protein production (Figure 4F–H).207
Alveolar bone defects have also been regenerated with 
nanometric-engineered scaffolds. The nanohydroxyapatite/
polyamide nanocomposite scaffolds produced by a phase-
separation method were combined with bone marrow 
stromal cells and then implanted into rabbit jaw bone. The 
results showed the enhancement of osteogenic markers in the 
implanted samples with cells, showing the ability of these scaf-
folds to stimulate osteogenesis, although the amount of new 
bone formed was not enhanced in the presence of the cells.225 
Similar results were obtained using nanosized β-tricalcium 
phosphate within a collagen matrix, which showed enhanced 
bone regeneration when implanted with MSCs.226
Drug delivery
The delivery of therapeutically relevant molecules is a 
promising approach to improve the regeneration ability of 
damaged tissues and to treat diseases effectively. These 
molecules are usually loaded in carriers, such as scaffolds 
or nanoparticles, to allow controlled and sustained release, 
ultimately influencing a series of biological processes, such 
as cell homing, attachment, proliferation, and differentiation. 
The therapeutic molecules should be safely loaded in large 
quantities and then delivered in a controlled and targeted 
manner.
Therefore, the design of delivery carriers is of special 
importance in the success of the delivery systems. When 
3D scaffolds are the carriers of the molecules to deliver, the 
signaling molecules can be combined within the 3D structure 
or on the surface of the scaffolds. As a result, the therapeutic 
molecules are released to the surrounding tissues and then act 
to regulate cellular functions. They can also be used as the 
tissue engineering matrices in the cultivation and differen-
tiation of stem cells. In these cases, the incorporation of the 
signaling molecules should be carefully considered on the 
basis of nanochemistry of scaffolds, for example, molecular 
bonding between scaffold networks and drug molecules. On 
the other hand, nanosized particles are the most common form 
of delivery carriers because the carriers are often intended 
to enter the cell membrane and sometimes even to the 
nucleus.227,228 Together with many different nanoparticulates 
made of either polymers or inorganics, their hybrids have 
been developed for the delivery of molecules. Those targeted 
for dental tissues are relatively less explored.
Among the target areas that need a delivery strategy 
of signaling molecules, periodontal disease is a common 
problematic issue in dentistry.229 The periodontal disease 
is primarily due to the bacterial infection that can possibly 
destroy the host tissues and eventually lead to tooth loosen-
ing. The treatment for periodontal diseases is based on two 
main approaches: the elimination of bacteria to avoid the 
progression of the disease and the regenerative therapy that 
may allow the regeneration of the damaged tissue.230 To this 
end, BMPs have been often used since they are involved in 
the osteogenic differentiation of stem cells showing the abil-
ity to regenerate PDL, cementum, as well as alveolar bone 
when administered from biomaterials.231–234 In a similar way, 
when dental pulp is infected, a common clinical treatment 
involves bacterial control and removal of whole pulpal tis-
sues. Therefore, the successful regeneration of odontoblasts, 
endothelial cells, fibroblasts, and even neurons is greatly 
needed to restore pulp tissue. Owing to the complexity of 
the cells involved in the regeneration process, many dif-
ferent growth factors, such as transforming growth factor 
(TGF-β1), BMP, and platelet-derived growth factor can be 
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used individually or in combination. The presence of dental 
caries requires ultimately the regenerative signals of both 
enamel and dentin, for which antibacterial drugs play a key 
role at the initial phase. Furthermore, for the regeneration of 
the temporomandibular joint, delivering molecules to target 
two different tissues (cartilage and bone) is required; thus, 
the use of dual factors such as BMP2 and TGF-β may be an 
appropriate delivery option.
Utilizing nanoparticles to deliver therapeutic molecules 
has been explored for periodontal regeneration. The most 
common molecular type is the small drug that can be anti-
bacterial in periodontal diseases. PLGA nanoparticles were 
developed to encapsulate minocycline for periodontal infec-
tions. The nanoparticles of size 85–424 nm have an entrap-
ping efficiency of up to 29.9%.235 The release was shown to 
be sustained for several weeks, which resulted in a consider-
able antibacterial effect compared to the minocycline-free 
nanoparticles.235 Similar nanoparticles composed of PLGA 
and poly(lactic acid) showed higher entrapment efficiencies 
of up to 63.8%, and their implantation in dogs showed that 
the nanoparticles loaded with triclosan were able to penetrate 
through the junction epithelium.221,236 A more osteoconduc-
tive vehicle for the delivery of tetracycline was developed 
using calcium-deficient HA nanoparticles with varying Ca/P 
ratios.237 The loaded drug showed sustained release of up to 
88% over a period of 5 days and considerable antibacterial 
effect. Furthermore, when the drug-loaded nanoparticles 
were placed in contact with PDL cells, the cell proliferation 
increased, suggesting that the use of HA nanoparticles as 
local drug delivery agents in periodontal treatment may be 
a good option.237
Growth factors have also been used for their therapeutic 
action in dental tissues. Compared to the common drug 
molecules, growth factors require water-based solutions in 
the nanoparticle processing. Some of the examples are illus-
trated in Figure 5. For this purpose, glycydil methacrylate, 
derivative dextran, and gelatin nanoparticles were prepared 
with a size of 53.7 nm to encapsulate BMP, which showed 
a sustained release of more than 12 days. Furthermore, the 
nanoparticles were shown to be biocompatible and could 
be used as a promising vehicle for the delivery of active 
molecules to the periodontium.238 Nanodiamonds, which 
are carbon nanoparticles of 4–5 nm, have also been used 
as a growth-factor carrier for the alveolar ridge augmenta-
tion. These have been shown to effectively physisorb and 
simultaneously deliver BMP2 and fibroblast growth factor 
and are able to induce the differentiation and proliferation 
of osteoblasts (Figure 5A and B).236
Owing to some concerns related to the lack of continuous 
supply of growth factors, gene therapy has been proposed as 
a possible solution.239 For the delivery of genetic molecules, 
the carriers should be positively charged to enable complexes 
with highly phosphorylated nucleic acids. Nanosized CaP 
particles were developed with 30–50 nm in size to load the 
platelet-derived growth factor gene. Results showed sig-
nificantly higher PDL fibroblast proliferation when placed 
in contact with the gene-complexed nanoparticles.239 In a 
similar way, BMP2 gene was loaded onto CaP nanoparticles. 
Dental pulp stem cells were able to uptake the complex par-
ticles and then express considerable levels of odontogenic 
differentiation.240 Alveolar bone regeneration has also been 
achieved through the delivery of polymeric nanoparticles 
that carry siRNA molecules for the interference of Sema4d, 
which is considered as a target gene for osteoporosis. The 
results showed, after injection in mice, that the siRNA-
loaded nanoparticles were able to increase significantly 
the formation of bone in the osteoporotic alveolar bone 
(Figure 5C and D).241
These nanoparticles are often incorporated into the 
3D matrices to allow scaffolding roles while maintaining 
the controlled and sustained release of the encapsulated 
molecules. Some examples are illustrated schematically in 
Figure 6. For instance, tetracycline-loaded nanoparticles of 
size around 130 nm were prepared using an ionic gelation 
method, which was then incorporated in a calcium sulfate 
cement matrix.242 The release pattern was sustained and 
presented an antibacterial effect as well as an enhanced ALP 
activity of human PDL cells.242 In a similar way, chitosan 
loaded with tetracycline was prepared as nanoparticles by a 
solution nebulization method, which was then incorporated 
into polycaprolactone (PCL) nanofibers. The release pattern 
of the drug from naked nanoparticles actually showed a burst 
with ~70% of release initially, which, however, was sustained 
significantly when incorporated within the PCL nanofiber 
structure.243 For the regeneration of mandible defects, the 
nanohydroxyapatite/collagen scaffolds were developed 
to deliver BMP2-derived peptides. The nanocomposite 
scaffolds showed sustained and controlled release of the 
peptide molecules as well as enhanced osteogenic capacity 
of marrow stromal cells.244 Nanocomposite scaffolds of HA 
nanoparticles with PCL were also reported to deliver BMP2 
and have an excellent ability to regenerate the mandibular 
bone defect in rabbits (Figure 6A–C).245 The BMP2-loaded 
nanohydroxyapatite/collagen/poly(lactic acid) constructs 
also showed a slow release of BMP2, which resulted in high 
osteogenic signaling of dental pulp stem cells. Furthermore, 
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when the BMP2-loaded scaffolds in combination with dental 
pulp stem cells were implanted in rabbits, the bone formation 
was similar to that of autologous bone, proving that BMP2 
was able to promote higher differentiation of the loaded stem 
cells, which in turn enhanced bone regeneration.246
Nanofibers have often been shown to be excellent matri-
ces for the sustained delivery of drugs mainly due to their high 
surface area. For PDL regeneration, nanofibers composed 
of PCL effectively encapsulated metronidazole benzoate 
and presented a low burst and sustained release of the drug 
up to 19 days.247 Similarly, doxycycline was encapsulated 
into PLGA nanospheres, which were then incorporated into 
PLLA nanofibrous scaffolds.248 The drug release was strongly 
dependent on the physical and chemical composition of the 
nanospheres, showing a complete release up to 6 weeks and 
a strong antibacterial effect (Figure 6D).248 Nanofibers have 
also been used for the treatment of pulp infections, using 
polydioxanone incorporating metronidazole or ciprofloxacin 
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Figure 5 (A, B) effects of BMP2 and FGF delivered by nanodiamonds on osteoblast differentiation and proliferation. ALP activity at 5 days was inhibited by the use of FGF 
with the nanodiamonds (ND-FGF), but was considerably increased in a dose-dependent manner when the ND-FGF were combined with BMP2 (ND-BF) or when the BMP2 
was administered alone (ND-BMP) (A). Osteoblast proliferation shows that BMP did not enhance proliferation (ND-BMP), whereas the presence of FGF alone (ND-FGF) 
or in combination with BMP significantly enhanced proliferation (ND-BF) (B). (C, D) Mandibular bone loss decreased by siRNA delivery. Histological observation of the 
mandibular inter-molar alveolar bone height loss significantly decreased in the presence of Sema4d-siRNA-loaded nanoparticles (C) compared to control (D). (A and B) 
Moore L, Gatica M, Kim H, Osawa e, Ho D, Journal of Dental Research, (92), 976–987. Copyright © 2013 by International & American Associations for Dental Research. 
Adapted by permission of SAGe Publications.236 (C and D) Zhang Y, wei L, Miron RJ, Zhang Q, Bian Z, Journal of Dental Research, (93), 1095–1100. Copyright © 2014 by 
International & American Associations for Dental Research. Adapted by permission of SAGE Publications.241
Abbreviations: BMP, bone morphogenetic protein; FGF, fibroblast growth factor.
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antibacterial drugs, which proved to be a good candidate for 
regenerative endodontics.249 In order to regenerate pulp and 
dentin, self-assembling peptide nanofibers encapsulating 
fibroblast growth factor, TGF-β1 and vascular endothelial 
growth factor, and dental pulp stem cells were used. These 
constructs led to the formation of vascularized connective 
tissues similar to dental pulp when implanted into immuno-
compromised mice.250 In an elegant study for the mandibular 
reconstruction, PLGA nanofibers-incorporated FTY720, 
which is a targeted agonist of S1P receptors 1 and 3 and is 
used as a cell recruiter to enhance bone regeneration, was 
explored (Figure 6E and F).251 The in vivo results showed 
that the loaded nanofibers were able to enhance blood vessel 
growth and the recruitment of macrophages, therefore prov-
ing their ability to regenerate critical size defects by recruiting 
specific macrophages and bone healing cells.251
Collectively, the delivery of therapeutic molecules, 
including drugs, growth factors, and genes, has been realized 
in the disease treatment or repair of dental tissues, with the 
use of different types of nanomaterials, including nanotopo-
logical scaffolds, nanoparticulate carriers, or combination 
of them. For the controllable and effective delivery of these 
bioactive molecules and the physicochemical properties of 
the carrier materials, the loading and compartment of the 
cargo molecules should be controlled at the molecular level, 
which ultimately is in great need of nanotechnology and 
nanoscale tailoring approach.
Concluding remarks
It can be seen that nanotechnology has been exploited in 
dentistry for some time, particularly in the development 
of restorative materials, with some significant success. 
Researchers have been able to overcome the technical chal-
lenges of processing these materials to exploit the proper-
ties at the nanoscale. Other areas offer significant promise, 
particularly in the prevention and treatment of oral biofilms. 
One point to note in the treatment of biofilms is that virtually 
all treatments have focused on the killing of bacteria in the 
biofilm and yet the bacteria only account for around 20% of 
the mass of the biofilm. The remainder is a polysaccharide 
matrix, and it may be judicious to consider targeting this 
matrix, which holds the bacterial community together rather 
than the bacteria themselves. Utilization of nanotechnology 
for therapeutics more generally in dentistry offers significant 
opportunities as the requirements can be limited in their 
complexity and thus the therapeutic can be more readily 
realized. One factor that should be taken into consideration 
when developing nanotechnologies is the cost of the device 
or therapy being developed. There are numerous complex 
therapies being developed to treat a wide range of diseases, 
not only in dentistry but also in biomedicine more broadly, 
but they will never see clinical use as they will be too expen-
sive to synthesize and thus too expensive for purchasers to 
procure. Cost is an important factor that is often forgotten 
in the development of new therapies and devices, but is ulti-
mately the hurdle that will decide if it progresses or fails.
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